| 1991 |
Human HSF1 was molecularly cloned and shown to encode a protein with four conserved leucine zipper motifs. HSF1 produced in E. coli in the absence of heat shock is active as a DNA-binding transcription factor, indicating that its intrinsic activity is under negative control in human cells. |
cDNA cloning, recombinant protein expression in E. coli, DNA-binding assay |
Proceedings of the National Academy of Sciences of the United States of America |
High |
1871105
|
| 1998 |
Hsp70 and the co-chaperone Hdj1 directly interact with the transactivation domain of HSF1 and repress HSF1 transcriptional activity without affecting its DNA binding or inducible phosphorylation, identifying chaperone-mediated repression of the transactivation domain as the primary autoregulatory mechanism during attenuation of the heat shock response. |
Co-immunoprecipitation, GAL4 fusion overexpression assay, transactivation reporter assay, gel-shift (EMSA) |
Genes & development |
High |
9499401
|
| 1994 |
mHSF1 binds extended heat shock element (HSE) sequences with higher cooperativity than mHSF2; the cooperative DNA-binding domain of mHSF1 maps to sequences within or adjacent to its DNA-binding domain and is transferable to mHSF2 in chimeric proteins. Single base substitutions in the HSE can alter affinity for a specific HSF. |
In vitro selection (SELEX), EMSA, mutagenesis of HSE, chimeric protein analysis |
Molecular and cellular biology |
High |
7935474
|
| 2003 |
The co-chaperone/ubiquitin ligase CHIP induces trimerization and transcriptional activation of HSF1, and CHIP-deficient mice are temperature-sensitive and undergo apoptosis in multiple organs after stress, establishing CHIP as a positive regulator of the HSF1 stress response. |
CHIP knockout mouse phenotype, cell-based trimerization assay, transcriptional reporter assay |
The EMBO journal |
High |
14532117
|
| 2015 |
HSF1 is a direct substrate of MEK; MEK phosphorylates and activates HSF1 to guard proteome stability, and MEK inhibition inactivates HSF1 causing protein destabilization, aggregation, and amyloidogenesis that is particularly toxic to tumor cells. |
In vitro kinase assay (MEK→HSF1), mass spectrometry, cell-based aggregation/amyloid assay, in vivo tumor model |
Cell |
High |
25679764
|
| 2015 |
NEDD4 ubiquitin E3 ligase mediates HSF1 degradation through the ubiquitin-proteasome system in the context of α-synuclein aggregation, and the acetylation status of Lys80 in the HSF1 DNA-binding domain modulates both HSF1 transcriptional activity and protein stability. SIRT1-mediated deacetylation attenuates NEDD4-dependent HSF1 degradation. |
Co-immunoprecipitation, ubiquitination assay, site-directed mutagenesis (K80), proteasome inhibitor treatment, neuroblastoma cell and mouse model |
Human molecular genetics |
High |
26503960
|
| 2019 |
Hsp70 binds HSF1 via its canonical substrate-binding domain, inhibiting HSF1 DNA-binding activity. During heat shock, cytoplasmic misfolded proteins derived from ongoing translation titrate Hsp70 away from HSF1, releasing HSF1 to activate the heat shock response. This chaperone-titration mechanism is reconstituted in vitro with purified budding yeast proteins. |
In vitro reconstitution with purified proteins, EMSA, translation inhibition genetics, yeast cell biology |
eLife |
High |
31552827
|
| 2020 |
Hsc70 and DnaJB1 dissociate trimeric HSF1 from DNA in vitro by successive cycles of entropic pulling that unzip the triple leucine-zipper, monomerizing HSF1 trimers. Hsc70 first binds a high-affinity site in the HSF1 transactivation domain to attenuate transcription, then at higher concentrations removes HSF1 from DNA to restore resting state. |
In vitro reconstitution with purified proteins, EMSA, biochemical dissociation assay, binding affinity measurements |
The EMBO journal |
High |
32490574
|
| 2022 |
HSF1 forms liquid-liquid phase-separated condensates at heat-shock-protein gene loci during heat shock, enriching transcription apparatus through co-phase separation to promote target gene transcription. Phosphorylation within the regulatory domain fine-tunes phase-separation capability. HSP70 disperses HSF1 condensates to attenuate transcription and prevents gel-like phase transition under extended stress. |
Super-resolution imaging, in vitro reconstitution of phase separation, high-throughput sequencing (ChIP/RNA-seq), phosphorylation site mutagenesis, FRAP |
Nature cell biology |
High |
35256776
|
| 2020 |
During prolonged heat stress, HSF1 nuclear condensates (foci) transition from small fluid liquid condensates to enlarged gel-like arrangements with immobilized HSF1; this transition reduces chaperone gene induction and correlates with increased apoptosis, revealing that foci dissolution promotes HSF1 transcriptional activity and cell survival. |
Live-cell microscopy, FRAP, single-cell analysis, multiplexed tissue imaging, biophysical characterization of condensate state |
Nature cell biology |
High |
32015439
|
| 2013 |
Blocking protein translation in cancer cells inactivates HSF1 transcriptional activity, linking translational flux to HSF1 regulation. Translation initiation inhibitors (rocaglates) deprived cancer cells of chaperone and energy support, selectively impairing proliferation. |
Chemical-genetic analysis, translation inhibition, HSF1 reporter assays, metabolic profiling |
Science (New York, N.Y.) |
High |
23869022
|
| 2019 |
AKT activates HSF1 via phosphorylation at Ser230, enabling HSF1 to physically neutralize soluble amyloid oligomers (AOs) directly, and shields HSP60 from AO assault, averting mitochondrial proteome collapse and apoptosis. |
In vitro kinase assay, phospho-site mutagenesis, direct binding assay between HSF1 and amyloid oligomers, cell viability and apoptosis assays |
Science advances |
High |
33177089
|
| 2022 |
AKT1 phosphorylates HSF1 at T142, S230, S326, and T527 (the latter being newly identified). Phosphorylation at T142 is necessary for HSF1 trimerization; S230, S326, and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9. AKT2 and other kinases (mTOR, p38, MEK1, DYRK2) phosphorylate S326 but are less potent activators than AKT1. |
In vitro kinase assay, mass spectrometry, site-directed mutagenesis, co-immunoprecipitation of TFIIB and CDK9, reporter assay |
The FEBS journal |
High |
35080342
|
| 2017 |
HSF1 recruits PARP1 through the scaffold protein PARP13; activated PARP1 dissociates from the HSF1-PARP13 complex upon DNA damage and redistributes to DNA lesions. HDAC1 maintains PARP1 in the ternary complex by deacetylating and inactivating it. Disruption of this complex impairs PARP1 redistribution, reducing DNA repair and gene expression. |
Co-immunoprecipitation, chromatin immunoprecipitation, reconstitution assay, HDAC inhibition, knockdown/KO cell lines |
Nature communications |
High |
29158484
|
| 2022 |
HSF1 recruits the TRRAP-TIP60 acetyltransferase complex to the HSP72 promoter in a manner dependent on phosphorylation of HSF1-S419 (mediated by PLK1). TIP60-mediated acetylation then recruits TRIM33, which cooperates with TRIM24 for mono-ubiquitination of histone H2B at K120, stabilizing the HSF1-transcription complex and establishing active chromatin. |
Co-immunoprecipitation, ChIP-seq, phospho-site mutagenesis, kinase inhibition (PLK1), histone modification analysis |
Nature communications |
High |
35906200
|
| 2015 |
IER5 interacts with protein phosphatase 2A (PP2A) and its B55 regulatory subunits; IER5/B55 expression leads to HSF1 dephosphorylation and activation of HSF1 target genes. B55 subunits directly bind HSF1, identifying IER5 as a positive feedback regulator that activates HSF1 via PP2A/B55-mediated dephosphorylation. |
Co-immunoprecipitation, gene reporter assay, dephosphorylation assay |
FEBS letters |
Medium |
25816751
|
| 2014 |
AMPKα phosphorylates HSF1 at Ser303, leading to transcriptional suppression of HSP70 and HSP27. PP2A B56δ dephosphorylates AMPKα at Thr172, relieving this suppression; PP2A B56δ physically interacts with AMPKα, establishing a PP2A-AMPKα-HSF1 signaling axis. |
Co-immunoprecipitation, kinase assay, phospho-site mutagenesis, siRNA knockdown, reporter assay |
Cellular signalling |
Medium |
24412756
|
| 2019 |
PIM2 kinase phosphorylates HSF1 at Thr120, disrupting HSF1 binding to the E3 ubiquitin ligase FBXW7 and thereby preventing FBXW7-mediated polyubiquitination and proteasomal degradation of HSF1. This stabilization promotes PD-L1 expression and breast cancer tumorigenesis. |
In vitro kinase assay, co-immunoprecipitation, site-directed mutagenesis (T120), ubiquitination assay |
Cancer research |
High |
31409638
|
| 2017 |
SIRT1-mediated deacetylation of HSF1 enhances its binding to HSP gene promoters and increases HSP70 and HSP40 expression to alleviate hepatic ER stress. Inhibition or knockout of SIRT1 diminishes exenatide-induced HSF1 deacetylation and HSP expression, establishing the SIRT1/HSF1/HSP pathway. |
ChIP assay, SIRT1 KO mouse model, lentiviral shRNA knockdown, Western blot |
Hepatology (Baltimore, Md.) |
Medium |
28439947
|
| 2022 |
HSF1 accumulates in the mitochondria in Huntington's disease models and activates dynamin-related protein 1 (Drp1) phosphorylation at S616 to promote mitochondrial fission; mitochondria-targeted HSF1 also suppresses SSBP1 oligomer formation, causing mitochondrial DNA deletion. A peptide inhibitor (DH1) blocking HSF1 mitochondrial localization abolishes these effects. |
Subcellular fractionation, mitochondria-targeting HSF1 construct overexpression, Drp1 phosphorylation assay, mouse model, human iPSC organoids, peptide inhibitor |
EMBO molecular medicine |
Medium |
35670111
|
| 2019 |
Hsp70 interacts with HSF1 via two independent sites in the N-terminal and C-terminal transcriptional activation domains (CE2 site and a newly identified N-terminal site) through its substrate-binding domain. Disrupting either site dysregulates HSF1 transcriptional activity, and dual disruption has synergistic effects on both gene expression and cellular fitness. |
Co-immunoprecipitation, binding domain mutagenesis, transcriptional assay (yeast Saccharomyces cerevisiae) |
The Journal of biological chemistry |
High |
31239354
|
| 2020 |
ABL2 tyrosine kinase directly interacts with HSF1 protein through its SH3 domain at a non-canonical proline-independent SH3 interaction motif, regulating HSF1 protein expression. Pharmacologic (allosteric, not ATP-competitive) inhibition of ABL2 disrupts this interaction and impairs HSF1 expression and HSF1-E2F transcriptional targets in brain-metastatic lung cancer cells. |
Co-immunoprecipitation, domain mapping (SH3), allosteric vs. ATP-competitive inhibitor comparison, shRNA knockdown, cell viability assay |
Proceedings of the National Academy of Sciences of the United States of America |
Medium |
33318173
|
| 2022 |
HSF2 physically and functionally interacts with HSF1 across diverse cancer types; HSF1 and HSF2 have similar chromatin occupancy and regulate a common set of cancer-relevant genes. Loss of either factor dysregulates nutrient stress responses and reduces tumor progression in xenografts. |
Co-immunoprecipitation, ChIP-seq, xenograft tumor model, genetic KD |
Science advances |
Medium |
35294249
|
| 2011 |
Loss of HSF1 prevents radiation-induced G2 arrest and reduces double-strand break repair; 53BP1 fails to accumulate at DNA damage sites in HSF1-deficient cells, revealing that HSF1 is required for DNA damage checkpoint activation and repair via the 53BP1 mediator pathway. |
HSF1 loss-of-function cell lines, flow cytometry (G2 arrest), gamma-H2AX foci, 53BP1 immunofluorescence |
Radiation research |
Medium |
21557666
|
| 2014 |
HSF1 protects neurons through a trimerization-independent and HSP-independent mechanism that requires cooperation with SIRT1 and classical HDACs, but not CaMK, PKA, CK2, or Raf-MEK-ERK and PI3K-Akt pathways. |
HSF1 trimerization-defective mutants, HSP70 knockdown, HSP90 blockade, HDAC inhibition, epistasis in neuronal cultures |
The Journal of neuroscience |
Medium |
24478344
|
| 2006 |
CHIP directly interacts with HSF1 via its tetratricopeptide repeat (TPR) domain to mediate HSF1 stability and nuclear translocation, suppressing IGF-IIR expression under physiological conditions. Doxorubicin attenuates the CHIP-HSF1 interaction, leading to proteasomal HSF1 degradation and IGF-IIR-dependent cardiomyocyte apoptosis. |
Co-immunoprecipitation, domain mapping (TPR domain), proteasome inhibitor assay, HSF1 overexpression/knockdown, cardiomyocyte apoptosis assay |
Cell death & disease |
Medium |
27809308
|
| 2021 |
HSF1 activation requires concurrent protein synthesis; misfolded proteins derived from ongoing translation—not pre-existing proteins—are the primary signal activating HSF1. Disrupting assembly or subcellular localization of newly synthesized proteins is sufficient to activate HSF1 in budding yeast. |
Systematic translation inhibition genetics, orthogonal stress induction, quantitative transcriptomics |
Molecular biology of the cell |
Medium |
34191586
|
| 2017 |
HSF1 directly binds the ATG4B gene promoter (site -1429 to -1417), transcriptionally upregulating ATG4B, which enhances protective autophagy in hepatocellular carcinoma cells treated with epirubicin. |
Luciferase reporter assay, chromatin immunoprecipitation (ChIP), ATG4B knockdown, autophagy flux assay |
Cancer letters |
Medium |
28889000
|
| 2015 |
Hsf4b interacts with HSF1 via N-terminal hydrophobic regions, impairs HSF1's intramolecular interaction between N- and C-terminal hydrophobic regions (which normally maintains HSF1 as inactive monomer), and causes cytosolic retention and proteasomal/lysosomal degradation of HSF1, thereby inhibiting HSP70 expression. |
Co-immunoprecipitation, domain mapping, proteasome/lysosome inhibitor assay, ChIP assay |
Biochimica et biophysica acta |
Medium |
25601714
|
| 2019 |
PDK3 localizes to the nucleus, binds HSF1, and disrupts HSF1 phosphorylation by GSK3β, preventing FBXW7-catalyzed polyubiquitination and proteasomal degradation of HSF1. HSF1 transcriptionally activates PDK3, forming a positive feedback loop that promotes glycolysis in chemoresistant cancer cells. |
Immunoprecipitation, subcellular fractionation, kinase inhibition (GSK3β), ubiquitination assay, ChIP |
Theranostics |
Medium |
31244938
|
| 2017 |
HSF1 directly binds the HMGB1 promoter and negatively regulates HMGB1 transcription, as demonstrated by ChIP assay and luciferase reporter assay. HSF1 knockdown enhances TLR4/MyD88/NF-κB-mediated airway inflammation through increased HMGB1 expression. |
ChIP assay, luciferase reporter assay, siRNA knockdown, OVA asthma mouse model |
Life sciences |
Medium |
31825792
|
| 2022 |
HSF1 directly binds Bdnf gene promoters I and IV in mouse hippocampus in vivo following kainic acid or footshock stress, co-occupying these promoters with phospho-CREB. HSF1 overexpression increases BDNF mRNA and protein via promoter activation, linking HSF1 to neuronal plasticity and neuroprotection through direct BDNF transcriptional control. |
ChIP-qPCR in vivo, immunohistochemistry, luciferase reporter assay, viral HSF1 overexpression in primary neurons |
Journal of neurochemistry |
Medium |
36227087
|
| 2021 |
WT p53 represses HSF1 activity by activating CDKN1A/p21, causing cell cycle inhibition and suppression of E2F target MLK3; MLK3 links cell cycle progression to MAPK-HSF1 activation. Loss of WT p53 (LOH) eliminates this repressive axis, unleashing HSF1 tumor-promoting functions. |
Genetic epistasis in colorectal tumor organoids, p53 LOH analysis, MLK3 knockdown, MAPK pathway analysis |
Nature communications |
Medium |
34188043
|
| 2017 |
In the absence of HSF1, NAD+ and ATP are not efficiently maintained in hepatic cells due to transcriptional repression of nicotinamide phosphoribosyltransferase (NAMPT) in the NAD+ salvage pathway. The resulting NAD+ deficiency reduces NAD+-dependent deacetylase (SIRT) activity, increases protein acetylation, and impairs mitochondrial integrity. |
HSF1 KO in hepatocytes, metabolic profiling (NAD+/ATP), ChIP (NAMPT promoter), SIRT activity assay |
The Journal of cell biology |
Medium |
28183717
|
| 2017 |
HSF1 upregulates HSF1 expression and activates CALM1 transcription to increase calmodulin (CaM) protein levels in hepatocytes, which then activates Akt independently of Ca2+ and insulin, repressing gluconeogenic gene expression. This FAM3C-HSF1-CaM-Akt axis controls hepatic glucose metabolism. |
Luciferase reporter assay (CALM1 promoter), Akt phosphorylation assay, siRNA knockdown, KO mouse model |
Diabetes |
Medium |
28246289
|
| 2014 |
HER2/ErbB2 overexpression constitutively activates HSF1 through the PI3K-AKT-mTOR axis, as shown by pharmacological (Lapatinib, CP724.714) and siRNA-mediated HER2 inhibition reducing phospho-Ser326 HSF1 levels. Inactivated HSF1 reduces HSP90 chaperone activity, destabilizing HSP90 clients including MIF, AKT, and mutant p53. |
Kinase inhibitors, siRNA knockdown, phospho-HSF1 (S326) immunoblot, in vivo ErbB2-driven breast cancer mouse model |
Cell death & disease |
Medium |
24384723
|
| 2017 |
HSF1 transcriptionally activates the PFKFB3 gene (a key glycolysis enzyme) in endometriosis cells, promoting glycolysis. ChIP or reporter assays confirm HSF1 binding to the PFKFB3 promoter. |
Gene expression analysis, glucose/lactate measurement, HSF1 inhibitor (KRIBB11), in vivo mouse endometriosis model |
Reproductive biology and endocrinology |
Low |
34107992
|
| 2006 |
A proapoptotic HSF1 target gene, Tdag51, is directly transactivated by HSF1 during heat stress. HSPs bind directly to the N-terminal pleckstrin-homology-like (PHL) domain of Tdag51, suppressing its C-terminal pro-death activity. Cell fate under proteotoxic stress is determined by the balance between Hsp and Tdag51 levels. |
Chromatin immunoprecipitation (ChIP), direct binding assay (Hsps to Tdag51 PHL domain), Tdag51-null mouse |
The EMBO journal |
Medium |
17024176
|
| 2022 |
Circadian disruption (chronic jetlag) disrupts the highly rhythmic nuclear trafficking of HSF1 in mouse lung, resulting in enhanced accumulation of HSF1 in the nucleus and increased expression of HSF1 target genes, promoting KRAS-driven lung tumorigenesis. |
Nuclear fractionation, ChIP/target gene expression, genetic and pharmacological HSF1 inhibition, mouse lung cancer model |
Science advances |
Medium |
36170373
|